Skip to main content

Bliss Kelly's Form 4 filing

Teladoc Health, Inc. (TDOC) · filed Sep 3, 2025

Accession no.
0001477449-25-000106
Filed
Sep 3, 2025
Trade date
Aug 29-Sep 2, 2025
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $35.7K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bliss KellyCIK 0002036989Officer (President, U.S. Group Health)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 29, 2025Common StockMOption exerciseAcquired+1,189––51,455Direct
Aug 29, 2025Common StockMOption exerciseAcquired+3,488––54,943Direct
Aug 29, 2025Common StockMOption exerciseAcquired+4,858––59,801Direct
Sep 2, 2025Common StockSSaleDisposed−4,700$7.59−$35,67355,101Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 29, 2025Common StockMOption exerciseDisposed−1,189$0.00$02,375Direct
Aug 29, 2025Common StockMOption exerciseDisposed−3,488$0.00$06,976Direct
Aug 29, 2025Common StockMOption exerciseDisposed−4,858$0.00$029,151Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)